Chengdu Okay Pharmaceutical

Chengdu Oukang Pharmaceutical is a specialized biopharmaceutical company based in China that focuses on the research, development, and large-scale production of plant-derived flavonoids and phytochemicals. The company is a global leader in the supply of high-purity natural extracts such as quercetin, rutin, and diosmin, which serve as active pharmaceutical ingredients (APIs) and nutritional supplements. Listed on the Beijing Stock Exchange, Oukang operates advanced manufacturing facilities that comply with international GMP standards to serve clients in the pharmaceutical, food, and cosmetic industries. Their product portfolio is primarily directed toward cardiovascular health, anti-inflammatory treatments, and vascular protection. By leveraging proprietary extraction and purification technologies, the company has established a significant presence in both domestic and international markets.